IRD Q3 2025 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena

IRDOpus Genetics, Inc.

$349M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-20.4% YoY

Gross Profit

$3M99.6% margin

Operating Income

-$8M-269.9% margin

Net Income

-$17M-566.9% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

+6.8%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$816,000

Balance Sheet

Total Assets

$36M

Total Liabilities

$30M

Stockholders' Equity

$6M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$4M	-20.4%
Gross Profit	$3M	$4M	-20.7%
Operating Income	-$8M	-$8M	-3.8%
Net Income	-$17M	-$8M	-131.9%